El jueves 13 de junio dará el seminario el Dr. Thomas Miller Co-director IPC4D and Principal Investigator, Institut Paoli-Calmettes, Cancer Research Center Marseille, (France). Co-founder, Paradigm Shift Therapeutics, Sonoma, California, USA, invitado por la Dra. María Calzada.

Título: Chemical biology strategies to selectively target CD47 partners for tumor immunotherapy

Discovery and development of immunomodulatory small molecules for anti-cancer immunotherapy. Structure-based drug development. Creation of novel preclinical immunotherapy assays (2D and 3D). Innovative chemical biology. Translational research. Public-Private partnerships for research innovation.